About Medpace
Medpace is a publicly listed company based in Cincinnati (United States) founded in 1992, and was acquired by Cinven in February 2014. It operates as an a range of clinical research services is offered by Medpace. The company has 5,900 employees. Medpace has completed 2 acquisitions, including MediTech and Symbios Clinical. Its chief executive is August Troendle. Its website medpace.com draws about 241 thousand monthly visits. Its Indian entity Medpace Clinical Research India Private Limited reported revenue of ₹19.34 Cr. Medpace offers products and services including CRO Services, Central Labs, and Bioanalytical Labs. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Full Service. Its competitors include Lambda Therapeutic, Dhiti Life Sciences, Ascada Research, JCCT and Diacrin and 1 more.
Company details
Medpace was founded in 1992 and is headquartered in Cincinnati, United States. Services as a clinical research organization are provided, encompassing various aspects of drug development and trial management. Operations are based in the healthcare sector, with focus on full-service support for pharmaceutical clients. Leadership is provided by August Troendle as CEO and President, and the domain medpace.com is utilized for online presence.
- Headquarters Cincinnati, United States
- Employees 5,900
- Stage Public
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website medpace.com
- Social LinkedIn Facebook YouTube
- Acquired by Cinven (Feb 2014)
- Legal Name Medpace Holdings, Inc.
Associated legal entities of Medpace
Medpace operates through Medpace Clinical Research India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Medpace Clinical Research India Private Limited CIN U24232MH2007PTC338993 | Active | 07 Mar 2007 | Thane, Maharashtra | ₹19.3 Cr | – | 3 | View details |
Products & Services of Medpace
Medpace offers a comprehensive portfolio of products and services, including CRO Services, Central Labs, and Bioanalytical Labs.
Manages end-to-end clinical trials for biotechs and sponsors.
Provides biomarker and safety testing for clinical research.
Conducts assays for drug development and preclinical studies.
Apps and channels of Medpace
Medpace publishes 1 mobile app with over 5K+ downloads; its YouTube channel Medpace, Inc. has 843 subscribers and 30 videos.
Videos from Medpace
The most watched videos on Medpace's YouTube channel, Medpace, Inc. (843 subscribers). Click a video to play it here.
More on Medpace, Inc..
Investors in Medpace
Medpace has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Cinven.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity investments and portfolio management services are provided by Cinven across various sectors. | – | cinven.com | - |
Investor details for Medpace
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Medpace Clinical Research India Private Limited (Medpace)
Medpace Clinical Research India Private Limited is the primary company behind Medpace. The board of Medpace Clinical Research India Private Limited currently have 3 directors; the longest-serving is Jesse Jacob Geiger, appointed in 2020. 10 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Jesse Jacob Geiger DIN 08936155 | Director | 16 Nov 2020 | 5 yrs 11 mo | Medpace Clinical Research India Private Limited |
| Stephen Paul Ewald DIN 08936156 | Director | 16 Nov 2020 | 5 yrs 11 mo | Medpace Clinical Research India Private Limited |
| Preeti Kabra DIN 03272393 | Director | 26 Apr 2023 | 3 yrs 5 mo | Medpace Clinical Research India Private Limited |
People of Medpace
670 people are tracked at Medpace (207 in leadership, 463 in team); the tracked headcount is 5,900.
| Name | Role | Group |
|---|---|---|
| CEO & President | Leadership | |
Reinilde Heyrman | Chief Medical Officer, Medical Department | Leadership |
Todd Meyers | VP, Business Development & Marketing | Leadership |
Traci Turner | VP, MRL Operations & MARC | Leadership |
Elisabetta Ferrino | Senior Director, Clinical Monitoring | Leadership |
Brian McQuade | Associate Director Clinical Monitoring | Leadership |
Susan Grundy | Executive Director, Business Development | Leadership |
Jessica Yehnert | Clinical Trial Manager/associate Director | Leadership |
Amanda Baird | Associate Director, Account Management | Leadership |
Ilona Pysz-Hosey | Associate Director, Clinical Trial Management | Leadership |
Christopher Huth | Sr. Clinical Trial Manager / Associate Director | Leadership |
Kirsty Blackwood Assoc. Cipd | HR Business Partner II | Leadership |
Beata Paluchowska | Medical Director | Leadership |
Aaron Logue | Director, Clinical Operations | Leadership |
Brent Tharp | Director, Business Development | Leadership |
Darlene Gaddy | Director, Business Development | Leadership |
Kevin Brady | Chief Financial Officer | Leadership |
| General Counsel, Chief Compliance Officer & Corporate Secretary | Leadership | |
Brandon Ebken | Chief Information Officer | Leadership |
Miaesha Campbell | Executive Director | Leadership |
650 more people are available in the full profile.
Complete people profiles for Medpace
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Medpace
Medpace is a publicly listed company on the NASDAQ with ticker symbol MEDP in USA, operating in the Commercial services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date11 Aug 2016
- Listed onNASDAQ: MEDP
- Listed entityMedpace Holdings, Inc.
- Exchange sectorCommercial services
- ISINUS58506Q1094
- Share price$609.89 (-1.64% on the day) · 2026-10-13
- Market capitalisation$17.02B
- Price to earnings35.8
- EPS (diluted, trailing year)$17.05
- Volume (last session)155,256
Financials of Medpace
Figures of Medpace Clinical Research India Private Limited, the primary company behind Medpace, for FY 2025. Revenue was ₹19.34 Cr (+36% year on year). Net profit was ₹72.3 Lakh (4% margin). EBITDA was ₹4.12 Cr (21% margin). Revenue has grown at a compounded annual rate of +48% over three years and +33% over five years.
- ₹19.34 CrRevenue · FY 2025 · +36% YoY
- ₹72.3 LakhNet profit · 4% margin
- ₹4.12 CrEBITDA · 21% margin
- ₹1 LakhPaid-up capital
- +48%Revenue CAGR, 3 years
- +33%Revenue CAGR, 5 years
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $2.53B | $451.1M | $563.1M |
| 2024 | $2.11B | $404.3M | $476.1M |
| 2023 | $1.89B | $282.6M | $363.1M |
| 2022 | $1.46B | $245.2M | $319.1M |
| 2021 | $1.14B | $181.4M | $236.0M |
Balance sheet, profit and loss, cash flow and ratios of Medpace Clinical Research India Private Limited are on its company page.
Detailed financial statements for Medpace
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Medpace
Medpace has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include MediTech and Symbios Clinical.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Clinical and regulatory consulting services are provided by MediTech. | meditech.nl | Vaals, Netherlands | 2017 | Nov 2012 | •••• | |
Full-service clinical research for medical devices is offered. | symbiosclinical.com | Minneapolis, United States | 2006 | Apr 2010 | •••• |
Complete acquisition details for Medpace
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Medpace
5 dated milestones of Medpace across 24 years, from founding to its latest funding, stage changes and deals.
- Founded Medpace is founded.
- Acquisition Acquires Symbios Clinical.
- Acquisition Acquires MediTech.
- Exit Acquired by Cinven.
- IPO Lists on the stock exchange (IPO).
Competitors of Medpace
Medpace has 6 listed competitors in our database. They include Lambda Therapeutic, Dhiti Life Sciences, Ascada Research, JCCT and Diacrin, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lambda-cro.com | 1998 | Ahmedabad, India | – | 1,011 | CRO with operations in India, US, Poland, Canada and UK. Winner of Frost & Sullivan 'CRO of the Year' - 2010 | |
| dhitilifesciences.com | 2010 | Delhi, India | – | 21 | Biotechnology company offering in vitro diagnostic products for healthcare sector | |
| ascadaresearch.org | 2021 | Fullerton, United States | – | 31 | Performs clinical research trials to evaluate investigational drugs and devices. | |
| jcct.com | 2005 | Lenexa, United States | – | – | CRO focused on early & end stage clinical trial services | |
| diacrin.com | 1989 | Boston, United States | – | – | Educational programs are provided by Diacrin since 1989. | |
| neomedlabs.com | 2015 | Laval, Canada | – | – | Contract research organisation offering immunology services for vaccines and immunotherapies |
Detailed competitors of Medpace
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Medpace
The website of Medpace (medpace.com) receives about 240.7K visits a month and ranks #213,697 among all websites worldwide, #6,995 in Biotechnology and Pharmaceuticals.
- Monthly visits240.7K
▲ 32.2% vs previous month
- Unique visitors86.4K
per month
- Global rank#213,697
among all websites
- Category rank#6,995
Health · Biotechnology and Pharmaceuticals
- Bounce rate48%
- Pages per visit3.0
- Average visit2 min 49 sec
- DevicesDesktop 72% · Mobile 28%
Websites whose visitors overlap most with Medpace. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| lambda-cro.com | 100% | 38.8K | #490,207 | View details | |
| iconplc.com | 97% | 476.9K | #92,950 | View details | |
abbott.co.in | abbott.co.in | 96% | – | #1,717,804 | – |
| vimta.com | 96% | 294.1K | #145,084 | View details | |
| premasbiotech.com | 96% | 2.2K | #9,884,529 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Medpace
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
10 companies that operate in the same segment as Medpace (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Medpace
Complete news archive for Medpace
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Medpace
Medpace was founded in 1992.
Medpace is headquartered in Cincinnati, United States. It is registered at Cincinnati, Ohio, United States.
August Troendle is the current CEO of Medpace.
Medpace has 5,900 employees.
The primary company behind Medpace, Medpace Clinical Research India Private Limited, reported revenue of ₹19.34 Cr for FY 2025, up 36% year on year.
Medpace was founded in 1992 and is headquartered in Cincinnati, United States. Services as a clinical research organization are provided, encompassing various aspects of drug development and trial management. Operations are based in the healthcare sector, with focus on full-service support for pharmaceutical clients. Leadership is provided by August Troendle as CEO and President, and the domain medpace.com is utilized for online presence.
Medpace's top competitors include Lambda Therapeutic, Dhiti Life Sciences and JCCT.
Medpace offers CRO Services, Central Labs, and Bioanalytical Labs.
Yes, Medpace is publicly traded on NASDAQ under the ticker symbol MEDP.
Medpace has made 2 acquisitions, including MediTech, and Symbios Clinical.
Medpace has 1 investor. Key investors include Cinven.
Medpace operates through Medpace Clinical Research India Private Limited.